 Robert Rogers
Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 16 | 2024 | 457 | 3.380 |
Why?
| | Lower Extremity | 8 | 2024 | 404 | 1.470 |
Why?
| | Angioplasty, Balloon | 4 | 2014 | 91 | 1.380 |
Why?
| | Endovascular Procedures | 7 | 2020 | 301 | 1.370 |
Why?
| | Stents | 7 | 2018 | 502 | 1.280 |
Why?
| | Tibial Arteries | 3 | 2017 | 12 | 1.250 |
Why?
| | Ischemia | 3 | 2020 | 406 | 1.060 |
Why?
| | Arterial Occlusive Diseases | 3 | 2011 | 80 | 1.010 |
Why?
| | Natriuretic Peptide, Brain | 4 | 2009 | 99 | 0.990 |
Why?
| | Angiography | 3 | 2024 | 196 | 0.870 |
Why?
| | Coronary Artery Disease | 2 | 2024 | 679 | 0.770 |
Why?
| | Blood Gas Monitoring, Transcutaneous | 1 | 2020 | 1 | 0.690 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2020 | 33 | 0.680 |
Why?
| | Ankle Brachial Index | 1 | 2020 | 36 | 0.670 |
Why?
| | Perfusion Imaging | 1 | 2020 | 56 | 0.670 |
Why?
| | Vascular Surgical Procedures | 5 | 2024 | 294 | 0.650 |
Why?
| | Foot | 1 | 2020 | 93 | 0.630 |
Why?
| | Platelet Aggregation Inhibitors | 3 | 2018 | 442 | 0.620 |
Why?
| | Early Termination of Clinical Trials | 1 | 2018 | 15 | 0.590 |
Why?
| | Sample Size | 1 | 2018 | 116 | 0.570 |
Why?
| | Patient Selection | 2 | 2018 | 662 | 0.540 |
Why?
| | Atherectomy | 2 | 2014 | 36 | 0.520 |
Why?
| | Cerebral Revascularization | 1 | 2015 | 19 | 0.490 |
Why?
| | Endarterectomy, Carotid | 1 | 2015 | 47 | 0.480 |
Why?
| | Carotid Artery Diseases | 1 | 2015 | 64 | 0.480 |
Why?
| | Aspirin | 1 | 2018 | 380 | 0.460 |
Why?
| | Treatment Outcome | 17 | 2024 | 10202 | 0.450 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 34 | 0.430 |
Why?
| | Vascular System Injuries | 1 | 2014 | 73 | 0.410 |
Why?
| | Femoral Artery | 1 | 2014 | 173 | 0.400 |
Why?
| | Vascular Calcification | 1 | 2014 | 107 | 0.390 |
Why?
| | Stroke | 3 | 2018 | 1070 | 0.360 |
Why?
| | Iliac Artery | 1 | 2010 | 55 | 0.330 |
Why?
| | Intermittent Claudication | 3 | 2015 | 118 | 0.330 |
Why?
| | Radiographic Image Enhancement | 1 | 2009 | 54 | 0.320 |
Why?
| | Elasticity Imaging Techniques | 1 | 2008 | 47 | 0.290 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2008 | 126 | 0.280 |
Why?
| | Coronary Vessels | 1 | 2009 | 239 | 0.280 |
Why?
| | Coronary Angiography | 1 | 2009 | 305 | 0.280 |
Why?
| | Carotid Stenosis | 2 | 2018 | 84 | 0.280 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1949 | 0.260 |
Why?
| | Humans | 31 | 2024 | 129271 | 0.260 |
Why?
| | Constriction, Pathologic | 3 | 2011 | 226 | 0.250 |
Why?
| | Electrocardiography | 1 | 2008 | 608 | 0.240 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 742 | 0.230 |
Why?
| | Heart Ventricles | 1 | 2009 | 781 | 0.230 |
Why?
| | Aged | 14 | 2021 | 22032 | 0.220 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 2003 | 0.220 |
Why?
| | Middle Aged | 14 | 2021 | 31091 | 0.200 |
Why?
| | Community Health Services | 2 | 2015 | 226 | 0.200 |
Why?
| | Risk Assessment | 5 | 2021 | 3233 | 0.190 |
Why?
| | Rivaroxaban | 1 | 2024 | 252 | 0.190 |
Why?
| | Ulcer | 1 | 2021 | 28 | 0.190 |
Why?
| | Hematoma | 1 | 2021 | 53 | 0.180 |
Why?
| | Male | 19 | 2021 | 63517 | 0.180 |
Why?
| | Leg | 2 | 2021 | 238 | 0.180 |
Why?
| | Walking | 3 | 2015 | 498 | 0.180 |
Why?
| | Syndrome | 1 | 2021 | 339 | 0.180 |
Why?
| | Prosthesis Design | 2 | 2014 | 306 | 0.170 |
Why?
| | Neck | 2 | 2017 | 94 | 0.170 |
Why?
| | Exercise Therapy | 2 | 2015 | 412 | 0.170 |
Why?
| | Radiography | 2 | 2014 | 796 | 0.160 |
Why?
| | Radiography, Interventional | 2 | 2011 | 105 | 0.160 |
Why?
| | Cardiology | 1 | 2022 | 261 | 0.160 |
Why?
| | Diabetes Complications | 1 | 2021 | 224 | 0.160 |
Why?
| | Vascular Diseases | 1 | 2022 | 240 | 0.160 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3080 | 0.160 |
Why?
| | Postoperative Complications | 3 | 2020 | 2473 | 0.160 |
Why?
| | Aorta | 1 | 2021 | 408 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 144 | 0.150 |
Why?
| | Acute Disease | 1 | 2021 | 978 | 0.150 |
Why?
| | Risk Factors | 6 | 2021 | 9746 | 0.150 |
Why?
| | Reperfusion | 1 | 2018 | 38 | 0.150 |
Why?
| | Time Factors | 7 | 2020 | 6543 | 0.150 |
Why?
| | Regional Blood Flow | 1 | 2020 | 463 | 0.150 |
Why?
| | Upper Extremity | 1 | 2018 | 95 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2017 | 39 | 0.130 |
Why?
| | Female | 16 | 2021 | 68556 | 0.130 |
Why?
| | Counseling | 2 | 2017 | 383 | 0.130 |
Why?
| | Retrospective Studies | 9 | 2021 | 14461 | 0.130 |
Why?
| | Colorado | 6 | 2018 | 4406 | 0.130 |
Why?
| | Heart Failure | 1 | 2009 | 2135 | 0.130 |
Why?
| | Patient Readmission | 1 | 2021 | 652 | 0.120 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2017 | 127 | 0.120 |
Why?
| | Life Style | 1 | 2017 | 459 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2016 | 136 | 0.110 |
Why?
| | Medicare | 1 | 2020 | 706 | 0.110 |
Why?
| | Exercise Test | 2 | 2015 | 612 | 0.110 |
Why?
| | Critical Illness | 1 | 2020 | 757 | 0.110 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2014 | 38 | 0.110 |
Why?
| | Rupture | 1 | 2014 | 91 | 0.110 |
Why?
| | Alloys | 1 | 2014 | 33 | 0.110 |
Why?
| | Double-Blind Method | 1 | 2018 | 1875 | 0.110 |
Why?
| | Comorbidity | 3 | 2017 | 1544 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 790 | 0.100 |
Why?
| | Ultrasonography, Interventional | 1 | 2014 | 128 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1047 | 0.100 |
Why?
| | Survival Analysis | 1 | 2015 | 1269 | 0.100 |
Why?
| | California | 3 | 2018 | 400 | 0.090 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2014 | 197 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 712 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1267 | 0.090 |
Why?
| | Vascular Patency | 1 | 2011 | 102 | 0.090 |
Why?
| | Creatinine | 2 | 2009 | 491 | 0.090 |
Why?
| | Logistic Models | 2 | 2018 | 1985 | 0.080 |
Why?
| | Coronary Restenosis | 1 | 2009 | 21 | 0.080 |
Why?
| | Diastole | 1 | 2009 | 148 | 0.080 |
Why?
| | United States | 4 | 2020 | 13828 | 0.080 |
Why?
| | Artifacts | 1 | 2009 | 126 | 0.080 |
Why?
| | Equipment Design | 1 | 2010 | 513 | 0.080 |
Why?
| | Aged, 80 and over | 3 | 2021 | 7055 | 0.070 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1040 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1021 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1497 | 0.070 |
Why?
| | Movement | 1 | 2009 | 269 | 0.070 |
Why?
| | Incidence | 3 | 2021 | 2636 | 0.070 |
Why?
| | Prognosis | 2 | 2017 | 3773 | 0.060 |
Why?
| | Recurrence | 2 | 2020 | 1005 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2740 | 0.060 |
Why?
| | Graft Rejection | 1 | 2009 | 598 | 0.060 |
Why?
| | Biomarkers | 3 | 2014 | 3968 | 0.060 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 376 | 0.060 |
Why?
| | Software | 1 | 2009 | 606 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2017 | 851 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1839 | 0.050 |
Why?
| | Heart Transplantation | 1 | 2009 | 721 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 3140 | 0.050 |
Why?
| | Body Mass Index | 1 | 2009 | 2272 | 0.040 |
Why?
| | Registries | 2 | 2021 | 1895 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 41 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 45 | 0.040 |
Why?
| | Hospitalization | 2 | 2020 | 2052 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 58 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 127 | 0.040 |
Why?
| | Retreatment | 1 | 2018 | 70 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2017 | 43 | 0.040 |
Why?
| | Aneurysm, False | 1 | 2017 | 47 | 0.030 |
Why?
| | Obesity | 1 | 2009 | 2879 | 0.030 |
Why?
| | Head | 1 | 2017 | 96 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 504 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 260 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2017 | 114 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 910 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 68 | 0.030 |
Why?
| | Clinical Competence | 1 | 2022 | 1016 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1266 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 645 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2015 | 4887 | 0.030 |
Why?
| | Heart | 1 | 2017 | 637 | 0.030 |
Why?
| | Quality of Life | 2 | 2015 | 2687 | 0.030 |
Why?
| | Physical Endurance | 1 | 2014 | 262 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2015 | 273 | 0.030 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2015 | 248 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 283 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1197 | 0.020 |
Why?
| | Adult | 2 | 2017 | 35497 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 867 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2014 | 381 | 0.020 |
Why?
| | Recovery of Function | 1 | 2015 | 641 | 0.020 |
Why?
| | Patient Compliance | 1 | 2015 | 563 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 1869 | 0.020 |
Why?
| | Program Evaluation | 1 | 2015 | 872 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1584 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1004 | 0.020 |
Why?
| | Endocardium | 1 | 2009 | 33 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3074 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2009 | 307 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2014 | 1266 | 0.020 |
Why?
| | Stroke Volume | 1 | 2009 | 592 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 527 | 0.020 |
Why?
| | Biopsy | 1 | 2009 | 1092 | 0.010 |
Why?
| | Hemodynamics | 1 | 2009 | 1090 | 0.010 |
Why?
| | Myocardium | 1 | 2009 | 978 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 5384 | 0.010 |
Why?
|
|
Rogers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|